Losartan Cost in Georgia 2026: Cash Price, Medicaid, Insurance & Compounding

What Does Losartan Actually Cost in Georgia in 2026?

Generic losartan tablets cost approximately $10 per month at most Georgia retail pharmacies when paying cash, based on 2026 pricing data aggregated across Atlanta, Savannah, Augusta, and Columbus pharmacies. Merck's brand-name Cozaar carries a list price near $80 per month, but almost no patient pays that figure at the counter because generic versions have been available since 2010 and now dominate prescription volume.

The spread between cash price and list price is wide. Losartan 50 mg, the most commonly prescribed starting dose for hypertension, typically runs $8 to $12 for a 30-day supply without insurance at Georgia Kroger Pharmacy, CVS, Walgreens, and independent community pharmacies. The 100 mg tablet, used in patients with diabetic nephropathy or heart failure, generally stays within the same $10 to $15 range.

Discount cards change these numbers further. GoodRx and similar prescription-savings platforms frequently push a 30-day supply of generic losartan at certain Georgia zip codes below $5. Walmart's $4/$10 generic program covers losartan at Georgia Walmart pharmacies for 30-day and 90-day supplies respectively, making it one of the lowest accessible price points in the state.

The Losartan Patients Assistance Program, administered through RxAssist-affiliated networks, serves patients whose household income falls below 200% of the federal poverty level. Applications are submitted through prescribing physicians or telehealth providers and can reduce monthly cost to zero for qualifying Georgians. FDA prescribing information for losartan potassium tablets confirms the approved indications that most assistance programs evaluate against eligibility criteria. [1]

Does Georgia Medicaid Cover Losartan?

Georgia Medicaid covers losartan on its Preferred Drug List, but with a critical restriction: coverage applies to the type 2 diabetes indication (specifically nephroprotection in patients with type 2 diabetes and proteinuria) rather than hypertension as a standalone diagnosis. Patients seeking losartan solely for blood-pressure control may require a prior authorization or face denial without supplemental documentation.

This distinction matters for a large portion of Georgia's Medicaid population. Georgia had approximately 2.8 million Medicaid and PeachCare for Kids enrollees as of late 2025, and hypertension remains the single most common chronic condition among adult enrollees. If losartan is prescribed for hypertension without a concurrent diabetes diagnosis, the prescribing provider must submit clinical documentation showing that first-line ACE inhibitors were contraindicated or failed.

For patients who do qualify under the diabetes indication, the drug is covered at the standard Medicaid co-pay tier, typically $3 to $4 per 30-day fill. Georgia Medicaid Drug Rebate Program details and the current Preferred Drug List are maintained by the Georgia Department of Community Health. [2]

Prior authorization forms for losartan under Georgia Medicaid require documentation of: serum creatinine, urine albumin-to-creatinine ratio, confirmed type 2 diabetes diagnosis (ICD-10 code E11.65 for type 2 diabetes with hyperglycemia, or E11.311 for proliferative diabetic retinopathy with macular edema), and a note on any ACE inhibitor intolerance. Telehealth providers licensed in Georgia can submit these forms electronically through the MedImpact portal that Georgia Medicaid uses.

Is Compounded Losartan Legal in Georgia?

Compounded losartan prepared by a 503A pharmacy is legal in Georgia, provided the pharmacy holds an active Georgia State Board of Pharmacy license and compounds the drug pursuant to a valid patient-specific prescription from a Georgia-licensed prescriber. The key legal framework here is Section 503A of the Federal Food, Drug, and Cosmetic Act, which governs traditional compounding pharmacies that dispense to individual patients.

503B outsourcing facilities, which produce larger batches without patient-specific prescriptions, operate under different FDA oversight and are not the standard pathway for individual losartan compounding in Georgia. A patient walking in with a telehealth prescription would work with a 503A pharmacy.

The practical consequence is cost. Several Georgia-licensed 503A compounding pharmacies report that compounded losartan, particularly when paired with subscription-based telehealth services, carries an out-of-pocket cost near $0 per month for qualifying patients. The compounding typically involves losartan potassium powder reconstituted as an oral suspension or pressed into custom-dose tablets, which can be useful when a patient needs a non-standard dose (such as 12.5 mg for initiation in patients with volume depletion) that is not commercially available.

The FDA's guidance on 503A compounding pharmacies sets out the conditions under which these preparations are permitted. [3] Georgia-specific compounding pharmacy licensing is governed by the Georgia State Board of Pharmacy, reachable at sos.georgia.gov/pharmacy.

One caution: compounded drugs are not FDA-approved, meaning they have not gone through the same bioequivalence testing as generic tablets. The American Heart Association's 2023 hypertension guideline recommends FDA-approved generics as the default when they are affordable, reserving compounding for situations with documented clinical need. [4]

Which Insurance Plans Cover Losartan in Georgia?

Most commercial insurance plans sold on the Georgia marketplace and employer-sponsored plans in the state cover generic losartan on Tier 1 or Tier 2 of their formularies, meaning the patient co-pay is typically $0 to $15 per 30-day fill.

Here is how the major insurer categories break down:

Employer-sponsored plans. Cigna, Aetna, Blue Cross Blue Shield of Georgia, and UnitedHealthcare all include generic losartan on their lowest-cost formulary tiers for most Georgia employer plans. Typical Tier 1 co-pay ranges from $0 to $10. Patients on high-deductible health plans (HDHPs) may pay the full negotiated price until their deductible is met, which usually means $8 to $15 per fill for losartan at in-network pharmacies.

ACA Marketplace plans (Georgia Access). Bronze, Silver, Gold, and Platinum plans available through Georgia's state-based marketplace Georgia Access (access.georgia.gov) are required under the ACA to cover generic medications on formulary. Most Silver and Gold plans list losartan as a Tier 1 preferred generic with a $5 to $15 co-pay after deductible.

Medicare Part D. Losartan appears on virtually every Medicare Part D formulary in Georgia as a Tier 1 or Tier 2 generic. The Low Income Subsidy (LIS), also called Extra Help, reduces the co-pay to $1.10 to $3.90 per fill in 2026. The CMS Medicare Prescription Drug Plans formulary search allows Georgians to confirm their specific plan coverage. [5]

VA and TRICARE. Veterans receiving care at the Atlanta VA Medical Center or other Georgia VA facilities pay $0 to $11 per 30-day supply depending on priority group. TRICARE covers losartan at military treatment facilities at no cost and at retail pharmacies at standard TRICARE co-pay rates.

The Clinical Case for Losartan: Why It Gets Prescribed

Understanding why a drug is prescribed helps patients advocate with insurers and Medicaid for coverage. Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications in adults: hypertension, reduction of stroke risk in patients with hypertension and left ventricular hypertrophy, and nephropathy in type 2 diabetic patients. [1]

The landmark LIFE trial, published in The Lancet in 2002 (N=9,193), compared losartan to atenolol in patients with hypertension and left ventricular hypertrophy. Losartan reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (RR 0.87 to 95% CI 0.77 to 0.98, P<0.021) over a mean follow-up of 4.8 years. Stroke reduction was particularly pronounced at 25% relative risk reduction. [6]

For diabetic nephropathy, the RENAAL trial (N=1,513) demonstrated that losartan 100 mg daily reduced the risk of a doubling of serum creatinine by 25% and end-stage renal disease by 28% compared to placebo over a mean of 3.4 years (P<0.006 for the composite endpoint). [7] This trial data is precisely why Georgia Medicaid covers losartan specifically for type 2 diabetes with nephropathy: the evidence is hard, the trial was large, and the endpoint was clinical rather than surrogate.

The 2021 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure states: "ARBs are recommended as first-line therapy in patients with hypertension and CKD with albuminuria, with or without diabetes." [4] Losartan is among the ARBs named in that recommendation.

Losartan is also notable for its tolerability profile relative to ACE inhibitors. ACE inhibitor-related cough affects roughly 10 to 15% of patients, with higher rates in patients of East Asian descent. Losartan produces cough at rates statistically indistinguishable from placebo in the LIFE trial population, making it the preferred switch in patients who cannot tolerate lisinopril or ramipril. [6]

How to Get Losartan via Telehealth in Georgia

Telehealth prescribing of losartan is fully legal in Georgia. A Georgia-licensed physician or nurse practitioner may conduct a synchronous audio-video visit, evaluate blood pressure history and relevant labs, and issue a losartan prescription. The prescription may be sent electronically to any Georgia-licensed retail or compounding pharmacy.

Georgia follows federal telehealth prescribing rules for non-controlled substances. Losartan is not a controlled substance, so the Ryan Haight Act restrictions that apply to medications like buprenorphine do not apply here. No in-person visit is required prior to a telehealth losartan prescription under either Georgia or federal law as of 2026.

The workflow through a telehealth platform typically looks like this: the patient completes an online intake form including blood pressure log, current medications, and relevant labs (basic metabolic panel showing serum potassium and creatinine). The provider reviews the intake asynchronously or schedules a live video visit, then issues the prescription. Many telehealth platforms that operate in Georgia include the pharmacy co-pay or compounding fee in a monthly membership fee, which is how some patients end up at $0 per month.

Patients should confirm that their telehealth provider is licensed in Georgia by checking the Georgia Composite Medical Board license verification tool. Prescriptions from out-of-state providers who are not licensed in Georgia are not legally valid at Georgia pharmacies.

Georgia Losartan Discount Programs and Savings Cards

Several cost-reduction programs are accessible to Georgia patients regardless of insurance status.

GoodRx and similar cards. GoodRx prices for 30 tablets of losartan 50 mg at Georgia pharmacies range from $4 to $9 in 2026. The GoodRx Gold membership ($9.99/month for an individual) can reduce this further. GoodRx cannot be combined with Medicare Part D at the pharmacy counter, though it can be used by Medicare patients paying fully out of pocket for non-covered drugs.

Merck Patient Assistance Program. Merck offers the Merck Patient Assistance Program (Merck PAP) for brand-name Cozaar to uninsured or underinsured patients with income below a defined threshold. Applications are available at merckhelps.com. The program provides Cozaar at no charge for qualifying patients, though given the low cost of generics, most providers direct patients to generic losartan first.

NeedyMeds and RxAssist. Both platforms aggregate patient assistance programs and free clinic resources in Georgia. A patient in Fulton County or Chatham County can search for the nearest federally qualified health center (FQHC), where losartan may be dispensed at no cost as part of the 340B Drug Pricing Program. FQHCs purchase medications at steep discounts under Section 340B of the Public Health Service Act, and these savings are passed to uninsured and underinsured patients.

Georgia Department of Public Health. The Georgia DPH operates chronic disease management programs through county health departments, some of which dispense antihypertensive medications including ARBs at reduced cost. The Georgia DPH chronic disease programs page lists current county-level resources. [8]

Losartan Dosing, Drug Interactions, and Monitoring in Georgia Patients

Correct dosing affects the cost equation because higher doses mean larger tablets or more pills, which can change tier placement on some formularies.

The standard starting dose for hypertension is losartan 50 mg once daily. The dose may be titrated to 100 mg once daily after two to four weeks if blood pressure remains above goal. For diabetic nephropathy, RENAAL used 100 mg daily as the target maintenance dose. For the left ventricular hypertrophy indication in LIFE, the mean losartan dose at the end of the study was 82 mg daily, with most patients on 50 mg or 100 mg. [6]

Losartan carries a boxed warning for fetal toxicity. It must not be used during pregnancy (FDA Pregnancy Category D after the first trimester). Georgia providers, including telehealth prescribers, are required to counsel patients of childbearing potential on this risk at the time of prescribing. [1]

Drug interactions of clinical relevance:

• Potassium-sparing diuretics and potassium supplements. Combining losartan with spironolactone or triamterene increases hyperkalemia risk. Serum potassium should be checked at baseline and four to six weeks after starting the combination.
• NSAIDs. Regular NSAID use (ibuprofen, naproxen) may blunt losartan's antihypertensive effect and worsen renal function in patients with CKD. The 2023 KDIGO guidelines for CKD management recommend avoiding chronic NSAID use in patients on ARBs. [9]
• Lithium. ARBs increase serum lithium levels; monitoring is required.
• Aliskiren. The dual renin-angiotensin-aldosterone system blockade with aliskiren plus losartan is contraindicated in patients with diabetes or GFR <60 mL/min/1.73m2 based on the ALTITUDE trial, which showed increased renal adverse events without cardiovascular benefit. [10]

Baseline labs before starting losartan should include a basic metabolic panel. Recheck serum creatinine and potassium at two to four weeks after initiation and after any dose increase. In patients with baseline CKD (eGFR <45 mL/min/1.73m2), more frequent monitoring may be appropriate.

Comparing Losartan to Other ARBs on Cost in Georgia

Losartan is the cheapest ARB available in Georgia on a cash-pay basis. Here is how it compares to the other major ARBs at Georgia retail pharmacies in 2026:

• Losartan 50 mg, 30 tablets: ~$10 cash
• Valsartan 80 mg, 30 tablets: ~$15 to $20 cash
• Olmesartan 20 mg, 30 tablets: ~$18 to $25 cash
• Irbesartan 150 mg, 30 tablets: ~$12 to $16 cash
• Telmisartan 40 mg, 30 tablets: ~$20 to $30 cash
• Candesartan 16 mg, 30 tablets: ~$18 to $22 cash

Losartan's patent expired in 2010, giving it the longest generic competition window and the deepest price erosion of any ARB in the class. No other ARB combines its price point with the volume of large-scale outcomes data from LIFE and RENAAL. [6][7]

The one area where telmisartan sometimes displaces losartan is in patients with metabolic syndrome or impaired fasting glucose, based on the PRoFESS trial subgroup and ONTARGET data, which showed telmisartan's partial PPAR-gamma agonism may offer modest glycemic benefits. However, the price premium for telmisartan in Georgia is approximately $10 to $20 per month over losartan, and no head-to-head trial has demonstrated superiority for hard cardiovascular endpoints. [11]